SynthesisMedicine2025
Efficacy and safety of sinus balloon catheter dilation versus functional endoscopic sinus surgery in the treatment of chronic sinusitis: A meta-analysis.
Synthesis in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis meta-analysis aimed to evaluate the efficacy and safety of sinus balloon catheter dilation (SBCD) versus functional endoscopic sinus surgery (FESS) in the treatment of chronic sinusitis (CRS).
methodsFour databases (PubMed, Embase, Web of Science, and Cochrane Library) were searched from the establishment of the databases to October 7, 2024, for randomized controlled trials comparing SBCD versus FESS in the treatment of CRS. Meta-analyses of Lund-Mackay score, sinonasal outcome test-20 score, complications, operating time and revision surgery were performed.
resultsTotally 14 randomized controlled trials were included for meta-analysis. Compared with FESS, SBCD provided a significantly lower postoperative sinonasal outcome test-20 score (standard mean difference = -0.25, 95% confidence intervals [CI]: -0.42 to -0.07, P < .01, I2 = 94%) and lower operating time (odds ratio [OR] = -5.00, 95%CI: -8.08 to -1.91, P = .001, I2 = 50%), while significantly reduced the incidence of complications (OR = 0.14, 95%CI: 0.08 to 0.26, P < .01, I2 = 65%). There was no significant difference between 2 groups regarding Lund-Mackay score (standard mean difference = 0.14, 95% CI: -0.04 to 0.32, P = .12, I2 = 15%) and revision surgery between 2 groups (OR = 0.51, 95% CI: 0.12 to 2.21, P = .37, I2 = 0%).
conclusionsThe results indicated that SBCD was an effective intervention for CRS, capable of substantially decreasing the occurrence of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.